KFS
Kurt F. Somerville Portfolio holdings
AUM
$594M
This Quarter Return
+0.91%
1 Year Return
+12.39%
3 Year Return
+68.79%
5 Year Return
+108.17%
10 Year Return
+271.21%
AUM
$451M
AUM Growth
+$451M
(-1.7%)
Cap. Flow
-$3.9M
Cap. Flow
% of AUM
-0.86%
Top 10 Holdings %
Top 10 Hldgs %
38.05%
Holding
116
New
3
Increased
19
Reduced
48
Closed
8
Top Buys
| 1 |
Analog Devices
ADI
|
$3.05M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$2.98M |
| 3 |
Danaher
DHR
|
$2.94M |
| 4 |
Chubb
CB
|
$1.08M |
| 5 |
J.M. Smucker
SJM
|
$915K |
Top Sells
| 1 |
Target
TGT
|
$2.9M |
| 2 |
Cisco
CSCO
|
$2.08M |
| 3 |
Johnson Controls International
JCI
|
$1.92M |
| 4 |
Perrigo
PRGO
|
$1.68M |
| 5 |
Helmerich & Payne
HP
|
$1.67M |
Sector Composition
| 1 | Technology | 23.26% |
| 2 | Healthcare | 22.42% |
| 3 | Industrials | 15.53% |
| 4 | Consumer Staples | 9.42% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
NXP Semiconductors
NXPI
$59.2B
| $6.74M | 1.49% |
68,805
-710
| -1% | -$69.6K |
|
27
Unilever
UL
$156B
| $6.74M | 1.49% |
165,583
+1,075
| +0.7% | +$43.7K |
|
28
IPG Photonics
IPGP
$3.45B
| $5.5M | 1.22% |
55,720
-9,645
| -15% | -$952K |
|
|
29
Analog Devices
ADI
$124B
| $4.38M | 0.97% |
60,241
+42,015
| +231% | +$3.05M |
|
30
GE Aerospace
GE
$292B
| $4.14M | 0.92% |
131,053
-3,444
| -3% | -$109K |
|
31
Xylem
XYL
$34.5B
| $3.92M | 0.87% |
79,138
+1,450
| +2% | +$71.8K |
|
|
32
SPDR S&P 500 ETF Trust
SPY
$653B
| $3.87M | 0.86% |
17,318
+13,318
| +333% | +$2.98M |
|
33
Chevron
CVX
$326B
| $3.47M | 0.77% |
29,527
-750
| -2% | -$88.2K |
|
34
Illumina
ILMN
$15.8B
| $3.21M | 0.71% |
25,058
+769
| +3% | +$98.5K |
|
|
35
J.M. Smucker
SJM
$11.8B
| $2.96M | 0.66% |
23,087
+7,145
| +45% | +$915K |
|
36
General Mills
GIS
$26.4B
| $2.81M | 0.62% |
45,486
-50
| -0.1% | -$3.09K |
|
37
Qualcomm
QCOM
$171B
| $2.62M | 0.58% |
40,119
+675
| +2% | +$44K |
|
38
Gilead Sciences
GILD
$140B
| $2.6M | 0.58% |
36,345
-14,565
| -29% | -$1.04M |
|
|
39
Cisco
CSCO
$268B
| $2.34M | 0.52% |
77,220
-68,920
| -47% | -$2.08M |
|
40
Merck
MRK
$214B
| $2.11M | 0.47% |
35,802
-2,100
| -6% | -$124K |
|
41
AbbVie
ABBV
$374B
| $1.99M | 0.44% |
31,840
-100
| -0.3% | -$6.26K |
|
|
42
Helmerich & Payne
HP
$2.08B
| $1.9M | 0.42% |
24,585
-21,670
| -47% | -$1.67M |
|
43
Colgate-Palmolive
CL
$67.9B
| $1.85M | 0.41% |
28,345
-760
| -3% | -$49.7K |
|
|
44
Target
TGT
$42B
| $1.48M | 0.33% |
20,491
-40,190
| -66% | -$2.9M |
|
45
Pfizer
PFE
$142B
| $1.46M | 0.32% |
44,854
-1,000
| -2% | -$32.5K |
|
46
Emerson Electric
EMR
$74.3B
| $1.41M | 0.31% |
25,226
-13,255
| -34% | -$739K |
|
47
Ionis Pharmaceuticals
IONS
$6.8B
| $1.33M | 0.29% |
27,781
-1,960
| -7% | -$93.9K |
|
48
State Street
STT
$32.6B
| $1.31M | 0.29% |
16,895
-727
| -4% | -$56.5K |
|
49
Bristol-Myers Squibb
BMY
$96B
| $1.29M | 0.29% |
22,000
-900
| -4% | -$52.6K |
|
50
Berkshire Hathaway Class B
BRK.B
$1.08T
| $1.26M | 0.28% |
7,700
-450
| -6% | -$73.3K |
|